The emergence of immunotherapy has profoundly changed the treatment model for triple-negative breast cancer (TNBC). But the heterogeneity of this disease res
They met : r/OMORI, horror sans altura
Frontiers Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Acquired resistance for immune checkpoint inhibitors in cancer immunotherapy: challenges and prospects
Frontiers What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Frontiers Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Models of drug resistance mechanisms following cancer targeted therapy.
Frontiers Acquired Resistance to Immune Checkpoint Blockades: The Underlying Mechanisms and Potential Strategies
Frontiers The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
Frontiers Editorial: CAR T-cells: novel therapeutic approaches in the new era of cancer immunotherapy
Frontiers Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Frontiers Role of hypoxia in the tumor microenvironment and targeted therapy
Translational Control of Immune Evasion in Cancer: Trends in Cancer, evade controls